Loading...
XNAS
AARD
Market cap239mUSD
Jun 12, Last price  
11.06USD
1D
-2.04%
1Q
10.49%
Name

Aardvark Therapeutics Inc

Chart & Performance

D1W1MN
XNAS:AARD chart
No data to show
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
Net income
-21m
-20,588,000
CFO
-18m
-18,087,000

Profile

IPO date
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FY
2024‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT